Subsequent Event (Details) - Subsequent Event - Vega Therapeutics, Inc. $ in Millions |
Jul. 06, 2026
USD ($)
|
|---|---|
| Subsequent Event [Line Items] | |
| Payments for asset acquisitions | $ 1,250.0 |
| Potential future milestone obligation (up to) | $ 750.0 |
| X | ||||||||||
- Definition Payments For Asset Acquisitions No definition available.
|
| X | ||||||||||
- Definition Amount of liability recognized from contingent consideration in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|